Citations (391)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (29)
Joseph Sleiman, Sara El Ouali, Taha Qazi, Benjamin Cohen, Scott R. Steele, Mark E. Baker & Florian Rieder. (2021) Prevention and Treatment of Stricturing Crohn’s Disease – Perspectives and Challenges. Expert Review of Gastroenterology & Hepatology 15:4, pages 401-411.
Read now
Read now
Kimberly L. Klages, Kristoffer S. Berlin, Jessica L. Cook, Mary E. Keenan, Katherine Semenkovich, Gabrielle G. Banks, Tiffany M. Rybak, Rachel L. Ankney, Kristina M. Decker, John R. Whitworth & Mark R. Corkins. (2021) Examining Risk Factors of Health-Related Quality of Life Impairments Among Adolescents with Inflammatory Bowel Disease. Behavioral Medicine 47:2, pages 140-150.
Read now
Read now
Robert Battat, Parambir S. Dulai, Vipul Jairath & Niels Vande Casteele. (2019) A product review of vedolizumab in inflammatory bowel disease. Human Vaccines & Immunotherapeutics 15:10, pages 2482-2490.
Read now
Read now
Lukasz Kwapisz, Vipul Jairath, Reena Khanna & Brian Feagan. (2017) Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn’s disease. Expert Opinion on Drug Metabolism & Toxicology 13:7, pages 793-801.
Read now
Read now
Guillaume Pineton de Chambrun, Pierre Blanc & Laurent Peyrin-Biroulet. (2016) Current evidence supporting mucosal healing and deep remission as important treatment goals for inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology 10:8, pages 915-927.
Read now
Read now
Megan E. McAuliffe, Stephan Lanes, Timothy Leach, Asit Parikh, Gerald Faich, Jane Porter, Crystal Holick, Daina Esposito, Yueqin Zhao & Irving Fox. (2015) Occurrence of adverse events among patients with inflammatory bowel disease in the HealthCore Integrated Research Database. Current Medical Research and Opinion 31:9, pages 1655-1664.
Read now
Read now
Johan Burisch & Pia Munkholm. (2015) The epidemiology of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:8, pages 942-951.
Read now
Read now
Adam Gater, Helen Kitchen, Louise Heron, Catherine Pollard, Jonas Håkan-Bloch, Lise Højbjerre, Brian Bekker Hansen & Martin Strandberg-Larsen. (2015) Development of a conceptual model evaluating the humanistic and economic burden of Crohn’s disease: implications for patient-reported outcomes measurement and economic evaluation. Expert Review of Pharmacoeconomics & Outcomes Research 15:4, pages 643-656.
Read now
Read now
Einar S. Björnsson & Anders Ekbom. (2015) Scandinavian epidemiological research in gastroenterology and hepatology. Scandinavian Journal of Gastroenterology 50:6, pages 636-648.
Read now
Read now
Morten H. Vatn & Arne K. Sandvik. (2015) Inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:6, pages 748-762.
Read now
Read now
Charlotte L. Kvasnovsky, Usman Aujla & Ingvar Bjarnason. (2015) Nonsteroidal anti-inflammatory drugs and exacerbations of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 50:3, pages 255-263.
Read now
Read now
Shmuel Odes & Dan Greenberg. (2014) A medicoeconomic review of early intervention with biologic agents in the treatment of inflammatory bowel diseases. ClinicoEconomics and Outcomes Research 6, pages 431-443.
Read now
Read now
Poonam Beniwal-Patel & Sumona Saha. (2014) The role of integrin antagonists in the treatment of inflammatory bowel disease. Expert Opinion on Biological Therapy 14:12, pages 1815-1823.
Read now
Read now
Cyrus P Tamboli, David B Doman & Amar Patel. (2011) Current and future role of biomarkers in Crohn’s disease risk assessment and treatment. Clinical and Experimental Gastroenterology 4, pages 127-140.
Read now
Read now
Ming Valerie Lin, Wojciech Blonski & Gary R Lichtenstein. (2010) What is the optimal therapy for Crohn’s disease: step-up or top-down?. Expert Review of Gastroenterology & Hepatology 4:2, pages 167-180.
Read now
Read now
G.R. D’Haens. (2009) TOP-DOWN THERAPY FOR CROHN’S DISEASE : RATIONALE AND EVIDENCE. Acta Clinica Belgica 64:6, pages 540-546.
Read now
Read now
Lotte Dinesen & Simon Travis. (2007) Targeting nanomedicines in the treatment of Crohn’s disease: focus on certolizumab pegol (CDP870). International Journal of Nanomedicine 2:1, pages 39-47.
Read now
Read now
C Janneke van der Woude & Daniel W Hommes. (2007) Are we ready for top-down therapy for inflammatory bowel diseases: pro. Expert Review of Gastroenterology & Hepatology 1:2, pages 243-248.
Read now
Read now
Magne Henriksen, Jørgen Jahnsen, Idar Lygren, Erling Aadland, Tom Schulz, Morten H. Vatn, Bjørn Moum & THE IBSEN STUDY GROUP. (2007) Clinical course in Crohn's disease: Results of a five-year population-based follow-up study (the IBSEN study). Scandinavian Journal of Gastroenterology 42:5, pages 602-610.
Read now
Read now
Frank L. Wolters, Catelijne Joling, Maurice G. Russel, Jildou Sijbrandij, Marion De Bruin, Selwyn Odes, Lene Riis, Pia Munkholm, Paolo Bodini, Barbara Ryan, Colm O'Morain, Ioannis A. Mouzas, Epameinondas Tsianos, Severine Vermeire, Estela Monteiro, Charles Limonard, Morten Vatn, Giovanni Fornaciari, Dolores Rodriguez, Wim Groot, Bjørn Moum, Reinhold W. Stockbrügger & ON BEHALF OF THE EUROPEAN COLLABORATIVE STUDY GROUP ON INFLAMMATORY BOWEL DISEASE (EC-IBD). (2007) Treatment inferred disease severity in Crohn's disease: Evidence for a European gradient of disease course. Scandinavian Journal of Gastroenterology 42:3, pages 333-344.
Read now
Read now
Asghar Qasim, Sharon McDonald, Shaji Sebastian, Ramona McLoughlin, Martin Buckley, Humphrey O'Connor & Colm O'Morain. (2007) Efficacy and safety of 6-thioguanine in the management of inflammatory bowel disease. Scandinavian Journal of Gastroenterology 42:2, pages 194-199.
Read now
Read now
Paul Rutgeerts, Karel Geboes. (2001) Understanding Inflammatory Bowel Disease&The Clinician's Perspective. The European Journal of Surgery 167:586, pages 66-72.
Read now
Read now
A. D. Guassora, C. Kruuse, O. Ø. Thomsen, V. Binder. (2000) Quality of Life Study in a Regional Group of Patients with Crohn Disease: A Structured Interview Study. Scandinavian Journal of Gastroenterology 35:10, pages 1068-1074.
Read now
Read now
Brian G. Feagan. (1998) Aminosalicylates for Active Disease and in the Maintenance of Remission in Crohn's Disease. The European Journal of Surgery 164:12, pages 903-909.
Read now
Read now
S.-W. Han, E. McColl, N. Steen, J. R. Barton, M. R. Welfare. (1998) The Inflammatory Bowel Disease Questionnaire: A Valid and Reliable Measure in Ulcerative Colitis Patients in the North East of England. Scandinavian Journal of Gastroenterology 33:9, pages 961-966.
Read now
Read now
S. M. MADSEN, H. S. THOMSEN, P. MUNKHOLM, S. DORPH, P. SCHLICHTING. (1998) Active Crohn's Disease and Ulcerative Colitis Evaluated by Low-Field Magnetic Resonance Imaging. Scandinavian Journal of Gastroenterology 33:11, pages 1193-1200.
Read now
Read now
P. ANDERSSON, G. OLAISON, G. BODEMAR, S. ALMER, M. ARVIDSSON, J. DABROSIN-SÖDERHOLM, P.-O. NYSTRÖM, K. SMEDH, M. STRÖM, R. SJÖDAHL. (1998) Low Symptomatic Load in Crohn's Disease with Surgery and Medicine as Complementary Treatments. Scandinavian Journal of Gastroenterology 33:4, pages 423-429.
Read now
Read now
B. Moum, A. Ekbom, M. H. Vatn, E. Aadland, J. Sauar, I. Lygren, T. Schulz, N. Stray & O. Fausa. (1997) Clinical Course during the 1st Year after Diagnosis in Ulcerative Colitis and Crohn's Disease: Results of a Large, Prospective Population-based Study in Southeastern Norway, 1990-93. Scandinavian Journal of Gastroenterology 32:10, pages 1005-1012.
Read now
Read now
P. Blomqvist & A. Ekbom. (1997) Inflammatory Bowel Diseases: Health Care and Costs in Sweden in 1994. Scandinavian Journal of Gastroenterology 32:11, pages 1134-1139.
Read now
Read now
Articles from other publishers (362)
Morris Gordon, Vassiliki Sinopoulou, Anthony K Akobeng, Shellie J Radford, Mohsen Eldragini, Ana-Maria Darie & Gordon William Moran. (2023) Infliximab for medical induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2023:12.
Crossref
Crossref
Johan Burisch. (2023) Long‐term disease course, cost and prognosis of inflammatory bowel disease: epidemiological studies of a European and a Danish inception cohort. APMIS 131:S147, pages 1-46.
Crossref
Crossref
T. Kucharzik, B. Verstockt & C. Maaser. (2023) Monitoring of patients with active inflammatory bowel disease. Frontiers in Gastroenterology 2.
Crossref
Crossref
Mads Damsgaard Wewer, Ebbe Langholz, Pia Munkholm, Flemming Bendtsen, Jakob Benedict Seidelin & Johan Burisch. (2023) Disease Activity Patterns of Inflammatory Bowel Disease—A Danish Nationwide Cohort Study 1995–2018. Journal of Crohn's and Colitis 17:3, pages 329-337.
Crossref
Crossref
Jennifer Claytor, Pushkar Kumar, Ashwin N. Ananthakrishnan, Jean-Frederic Colombel, Manasi Agrawal & Ryan C. Ungaro. (2023) Mild Crohn’s Disease: Definition and Management. Current Gastroenterology Reports 25:3, pages 45-51.
Crossref
Crossref
Mitsuro Chiba & Norikazu Morita. (2023) Incorporation of Plant-Based Diet Surpasses Current Standards in Therapeutic Outcomes in Inflammatory Bowel Disease. Metabolites 13:3, pages 332.
Crossref
Crossref
James Irwin, Anton Lord, Emma Ferguson, Lisa A. Simms, Katherine Hanigan, Carlos A. Montoya & Graham Radford-Smith. (2022) A Method Using Longitudinal Laboratory Data to Predict Future Intestinal Complication in Patients with Crohn’s Disease. Digestive Diseases and Sciences 68:2, pages 596-607.
Crossref
Crossref
Dong Yoon Han, Myung-Won You, Chi Hyuk Oh & Seong Jin Park. (2023) Related Factors for Unfavorable Disease Course in Patients with Crohn’s Disease: An Observational Retrospective Study. Diagnostics 13:2, pages 273.
Crossref
Crossref
Benjamin Sahn & James Markowitz. 2023. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
93
102
.
Amy Grant & Anthony Otley. 2023. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
711
727
.
David J. Bartlett, Guilherme Piovezani Ramos, Joel G. Fletcher & David H. Bruining. (2022) Imaging Evaluation of Inflammatory Bowel Disease Complications. Gastrointestinal Endoscopy Clinics of North America 32:4, pages 651-673.
Crossref
Crossref
Choong Wui Cho, Myung-Won You, Chi Hyuk Oh, Chang Kyun Lee & Sung Kyoung Moon. (2022) Long-term Disease Course of Crohn’s Disease: Changes in Disease Location, Phenotype, Activities, and Predictive Factors. Gut and Liver 16:2, pages 157-170.
Crossref
Crossref
Andreas Sturm, Raja Atreya, Dominik Bettenworth, Bernd Bokemeyer, Axel Dignaß, Robert Ehehalt, Christoph Germer, Philip C. Grunert, Ulf Helwig, Klaus Herrlinger, Peter Kienle, Martin E. Kreis, Torsten Kucharzik, Jost Langhorst, Christian Maaser, Johann Ockenga, Claudia Ott, Britta Siegmund, Sebastian Zeißig & Andreas Stallmach. (2022) Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Zeitschrift für Gastroenterologie 60:03, pages 332-418.
Crossref
Crossref
Ulf Helwig, Imma Fischer, Leonie Hammer, Stefanie Kolterer, Stefan Rath, Christian Maaser & Torsten Kucharzik. (2022) Transmural Response and Transmural Healing Defined by Intestinal Ultrasound: New Potential Therapeutic Targets?. Journal of Crohn's and Colitis 16:1, pages 57-67.
Crossref
Crossref
Johan Burisch, Søren Lophaven, Ebbe Langholz & Pia Munkholm. (2021) The clinical course of Crohn’s disease in a Danish population‐based inception cohort with more than 50 years of follow‐up, 1962‐2017. Alimentary Pharmacology & Therapeutics 55:1, pages 73-82.
Crossref
Crossref
Robin Dalal & David Schwartz. 2022. Management of Inpatient Inflammatory Bowel Disease. Management of Inpatient Inflammatory Bowel Disease
1
9
.
Samuel Sassine, Souhila Zekhnine, Marwa Qaddouri, Lisa Djani, Christine Cambron‐Asselin, Mathieu Savoie‐Robichaud, Yi Fan Lin, Kelly Grzywacz, Véronique Groleau, Martha Dirks, Éric Drouin, Ugur Halac, Valérie Marchand, Chloé Girard, Olivier Courbette, Natalie Patey, Dorothée Dal Soglio, Colette Deslandres & Prévost Jantchou. (2021) Factors associated with time to clinical remission in pediatric luminal Crohn's disease: A retrospective cohort study. JGH Open 5:12, pages 1373-1381.
Crossref
Crossref
Daxin Guo, Ke Jiang, Jiaze Hong, Mengting Zhang, Yetan Shi & Bin Zhou. (2021) Association between vedolizumab and postoperative complications in IBD: a systematic review and meta-analysis. International Journal of Colorectal Disease 36:10, pages 2081-2092.
Crossref
Crossref
Nikolas Plevris, James Fulforth, Mathew Lyons, Spyros I. Siakavellas, Philip W. Jenkinson, Cher S. Chuah, Laura Lucaciu, Rebecca J. Pattenden, Ian D. Arnott, Gareth-Rhys Jones & Charlie W. Lees. (2021) Normalization of Fecal Calprotectin Within 12 Months of Diagnosis Is Associated With Reduced Risk of Disease Progression in Patients With Crohn’s Disease. Clinical Gastroenterology and Hepatology 19:9, pages 1835-1844.e6.
Crossref
Crossref
Henit Yanai, Idan Goren, Lihi Godny, Nitsan Maharshak, Yulia Ron, Irit Avni Biron, Haim Leibovitzh, Hagar Banai Eran, Maya Aharoni Golan, Keren Rabinowitz, Tomer Ziv Baran, Inbar Lavie, Karin Yadgar, Keren Zonensain, Uri Kopylov, Shomron Ben Horin, Rami Eliakim, Matti Waterman, Yehuda Chowers, Shay Ben-Shachar & Iris Dotan. (2021) Early Indolent Course of Crohn’s Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable. Clinical Gastroenterology and Hepatology 19:8, pages 1564-1572.e5.
Crossref
Crossref
Marco Salice, Fernando Rizzello, Dolores Sgambato, Carlo Calabrese, Francesco Manguso, Silvio Laureti, Matteo Rottoli, Gilberto Poggioli & Paolo Gionchetti. (2021) Long term remission after ileorectal anastomosis in Crohn's colitis. Digestive and Liver Disease 53:5, pages 592-597.
Crossref
Crossref
Steven J Edwards, Samantha Barton, Mariana Bacelar, Charlotta Karner, Peter Cain, Victoria Wakefield & Gemma Marceniuk. (2021) Prognostic tools for identification of high risk in people with Crohn’s disease: systematic review and cost-effectiveness study. Health Technology Assessment 25:23, pages 1-138.
Crossref
Crossref
Stjepan Rudan, Rudika Gmajnić & Sanda Pribić. 2021. Topics in Primary Care Medicine. Topics in Primary Care Medicine.
Rune Wilkens, Kerri L. Novak, Christian Maaser, Remo Panaccione & Torsten Kucharzik. (2021) Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives. Therapeutic Advances in Gastroenterology 14, pages 175628482110066.
Crossref
Crossref
Bun Kim, Jisuk Chae, Eun Hye Kim, Hyuk In Yang, Jae Hee Cheon, Tae Il Kim, Won Ho Kim, Justin Y. Jeon & Soo Jung Park. (2021) Physical activity and quality of life of patients with inflammatory bowel disease. Medicine 100:27, pages e26290.
Crossref
Crossref
Kaoru Takabayashi, Naoki Hosoe, Motohiko Kato, Yukie Hayashi, Kosaku Nanki, Kayoko Fukuhara, Yohei Mikami, Shinta Mizuno, Tomohisa Sujino, Makoto Mutaguchi, Makoto Naganuma, Naohisa Yahagi, Haruhiko Ogata & Takanori Kanai. (2020) Significance of endoscopic deep small bowel evaluation using balloon-assisted enteroscopy for Crohn’s disease in clinical remission. Journal of Gastroenterology 56:1, pages 25-33.
Crossref
Crossref
Seok-Hoo Jeong, Ja Sung Choi, Jin Woo Kim, Hee Man Kim, Hyun-Soo Kim, Jong Pil Im, Joo Sung Kim, You Sun Kim, Jae Hee Cheon, Won Ho Kim, Byong Duk Ye, Young-Ho Kim & Dong Soo Han. (2020) Clinical Features of Intra-Abdominal Abscess and Intestinal Free-Wall Perforation in Korean Patients with Crohn’s Disease: Results from the CONNECT Study. Journal of Clinical Medicine 10:1, pages 116.
Crossref
Crossref
B. Sensi, L. Siragusa, C. Efrati, L. Petagna, M. Franceschilli, V. Bellato, A. Antonelli, C. Arcudi, M. Campanelli, S. Ingallinella, A. M. Guida & A. Divizia. (2020) The Role of Inflammation in Crohn’s Disease Recurrence after Surgical Treatment. Journal of Immunology Research 2020, pages 1-14.
Crossref
Crossref
Jun Hwan Yoo, Stefan Holubar & Florian Rieder. (2020) Fibrostenotic strictures in Crohn’s disease. Intestinal Research 18:4, pages 379-401.
Crossref
Crossref
Johan Burisch, Daniel Bergemalm, Jonas Halfvarson, Viktor Domislovic, Zeljko Krznaric, Adrian Goldis, Jens F Dahlerup, Pia Oksanen, Pekka Collin, Luisa de Castro, Vicent Hernandez, Svetlana Turcan, Elena Belousova, Renata D’Incà, Alessandro Sartini, Daniela Valpiani, Martina Giannotta, Ravi Misra, Naila Arebi, Dana Duricova, Martin Bortlik, Kelly Gatt, Pierre Ellul, Natalia Pedersen, Jens Kjeldsen, Karina W Andersen, Vibeke Andersen, Konstantinos H Katsanos, Dimitrios K Christodoulou, Shaji Sebastian, Luisa Barros, Fernando Magro, Jóngerð MM Midjord, Kári R Nielsen, Riina Salupere, Hendrika AL Kievit, Gediminas Kiudelis, Juozas Kupčinskas, Mathurin Fumery, Corinne Gower‐Rousseau, Ioannis P Kaimakliotis, Doron Schwartz, Selwyn Odes, Laszlo Lakatos, Peter L Lakatos, Ebbe Langholz & Pia Munkholm. (2020) The use of 5‐aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow‐up – an Epi‐IBD study. United European Gastroenterology Journal 8:8, pages 949-960.
Crossref
Crossref
J.C. Andreu-Ballester, I. Catalán-Serra, R. Gil-Borrás, P. Marqués-García, C. García-Ballesteros, F. López Chuliá & C. Cuéllar. (2020) Gammadelta T cells as a predictor of surgical relapse of Crohn's disease. Clinics and Research in Hepatology and Gastroenterology 44:4, pages 586-597.
Crossref
Crossref
Yasuhiro Morita, Shigeki Bamba, Osamu Inatomi, Kenichiro Takahashi, Takayuki Imai, Masaki Murata, Masashi Ohno, Masaya Sasaki, Tomoyuki Tsujikawa & Akira Andoh. (2020) Prototype single-balloon enteroscopy with passive bending and high force transmission improves depth of insertion in the small intestine. Intestinal Research 18:2, pages 229-237.
Crossref
Crossref
Marina Moreira de Castro, Ligiana Pires Corona, Lívia Bitencourt Pascoal, Josiane Érica Miyamoto, Leticia Martins Ignacio-Souza, Maria de Lourdes Setsuko Ayrizono, Marcio Alberto Torsoni, Adriana Souza Torsoni, Raquel Franco Leal & Marciane Milanski. (2020) Dietary Patterns Associated to Clinical Aspects in Crohn’s Disease Patients. Scientific Reports 10:1.
Crossref
Crossref
Oleg Knyazev, Anna Kagramanova, Albina Lischinskaya, Irina Korneeva, Mariya Zvyaglova, Anait Babayan, Anatoliy Konoplyannikov & Asfold Parfenov. (2020) Stem Cell Therapy for Perianal Crohn’s Disease. Proceedings of the Latvian Academy of Sciences. Section B. Natural, Exact, and Applied Sciences. 74:2, pages 68-74.
Crossref
Crossref
Bobby Lo, Ida Vind, Marianne Kajbaek Vester-Andersen, Flemming Bendtsen & Johan Burisch. (2020) Direct and Indirect Costs of Inflammatory Bowel Disease: Ten Years of Follow-up in a Danish Population-based Inception Cohort. Journal of Crohn's and Colitis 14:1, pages 53-63.
Crossref
Crossref
Nina A. Saxena & Scott D. Lee. 2020. Encyclopedia of Gastroenterology. Encyclopedia of Gastroenterology
739
753
.
Antje Timmer. 2020. Chronisch-entzündliche Darmerkrankungen. Chronisch-entzündliche Darmerkrankungen
13
50
.
Léon Maggiori, Antoine Brouquet, Philippe Zerbib, Jérémie H. Lefevre, Quentin Denost, Adeline Germain, Eddy Cotte, Laura Beyer-Berjot, Nicolas Munoz-Bongrand, Véronique Desfourneaux, Amine Rahili, Jean-Pierre Duffas, Karine Pautrat, Christine Denet, Valérie Bridoux, Guillaume Meurette, Jean-Luc Faucheron, Jérome Loriau, Regis Souche, Eric Vicaut, Yves Panis & Stéphane Benoist. (2019) Penetrating Crohn Disease Is Not Associated With a Higher Risk of Recurrence After Surgery. Annals of Surgery 270:5, pages 827-834.
Crossref
Crossref
Corinne E.G.M. Spooren, Dion S.J. Wintjens, Marin J. de Jong, Andrea E. van der Meulen-de Jong, Mariëlle J. Romberg-Camps, Marco C. Becx, Jeroen P. Maljaars, Ad A. van Bodegraven, Nofel Mahmmod, Tineke Markus, Wim M. Hameeteman, Ad A.M. Masclee, Bjorn Winkens, Daisy M.A.E. Jonkers & Marie J. Pierik. (2019) Risk of impaired nutritional status and flare occurrence in IBD outpatients. Digestive and Liver Disease 51:9, pages 1265-1269.
Crossref
Crossref
Amy L Lightner, Fabian Grass, Ahmad Alsughayer, Molly M Petersen, Laura E Raffals & Edward V LoftusJrJr. (2019) Postoperative Outcomes in Ustekinumab-Treated Patients Undergoing Abdominal Operations for Crohn’s Disease: Single-Center Series. Crohn's & Colitis 360 1:2.
Crossref
Crossref
Jenna L. Koliani-Pace & Corey A. Siegel. (2019) Prognosticating the Course of Inflammatory Bowel Disease. Gastrointestinal Endoscopy Clinics of North America 29:3, pages 395-404.
Crossref
Crossref
Robert Battat, Christopher Ma, Vipul Jairath, Reena Khanna & Brian G. Feagan. (2019) Benefit–Risk Assessment of Vedolizumab in the Treatment of Crohn’s Disease and Ulcerative Colitis. Drug Safety 42:5, pages 617-632.
Crossref
Crossref
Erwin Dreesen & Ann Gils. (2019) Pharmacodynamic Monitoring of Biological Therapies in Chronic Inflammatory Diseases. Therapeutic Drug Monitoring 41:2, pages 131-141.
Crossref
Crossref
Dario Sorrentino. (2019) Low-dose biologics to treat inflammatory bowel disease. Ready for prime time?. Digestive and Liver Disease 51:4, pages 609-610.
Crossref
Crossref
Hannah Mitchell, Judi Porter, Peter R. Gibson, Jacqueline Barrett & Mayur Garg. (2018) Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research. Alimentary Pharmacology & Therapeutics 49:2, pages 124-139.
Crossref
Crossref
Zsuzsanna Kurti, Akos Ilias, Lorant Gonczi, Zsuzsanna Vegh, Petra Fadgyas-Freyler, Gyula Korponay, Petra A. Golovics, Barbara D. Lovasz & Peter L. Lakatos. (2018) Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database. BMC Gastroenterology 18:1.
Crossref
Crossref
Francisco J. Melo & Sofia Magina. (2018) Clinical management of Anti-TNF-alpha-induced psoriasis or psoriasiform lesions in inflammatory bowel disease patients: a systematic review. International Journal of Dermatology 57:12, pages 1521-1532.
Crossref
Crossref
Shameer J. Mehta, Amy Lewis, Anke Nijhuis, Rosemary Jeffery, Paolo Biancheri, Antonio Di Sabatino, Roger Feakins, Andrew Silver & James Oliver Lindsay. (2018) Epithelial down‐regulation of the miR‐200 family in fibrostenosing Crohn's disease is associated with features of epithelial to mesenchymal transition. Journal of Cellular and Molecular Medicine 22:11, pages 5617-5628.
Crossref
Crossref
Amy L. Lightner, Chung Sang Tse, D. Dean PotterJr.Jr. & Christopher Moir. (2018) Postoperative outcomes in vedolizumab-treated pediatric patients undergoing abdominal operations for inflammatory bowel disease. Journal of Pediatric Surgery 53:9, pages 1706-1709.
Crossref
Crossref
R. Banerjee, P. Pal, B. G. Girish & D. N. Reddy. (2018) Risk factors for diagnostic delay in Crohn's disease and their impact on long-term complications: how do they differ in a tuberculosis endemic region?. Alimentary Pharmacology & Therapeutics 47:10, pages 1367-1374.
Crossref
Crossref
Marijn C Visschedijk, Lieke M Spekhorst, Shih-Chin Cheng, Ellen S van Loo, B H Dianne Jansen, Tjasso Blokzijl, Hyunsuk Kil, Dirk J de Jong, Marieke Pierik, Jeroen P W J Maljaars, C Janneke van der Woude, Adriaan A van Bodegraven, Bas Oldenburg, Mark Löwenberg, Vincent B Nieuwenhuijs, Floris Imhann, Suzanne van Sommeren, Rudi Alberts, Ramnik J Xavier, Gerard Dijkstra, Klaas Nico Faber, C Marcelo Aldaz, Rinse K Weersma & Eleonora A M Festen. (2018) Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn’s Disease. Journal of Crohn's and Colitis 12:5, pages 582-588.
Crossref
Crossref
Gary R Lichtenstein, Edward V Loftus, Kim L Isaacs, Miguel D Regueiro, Lauren B Gerson & Bruce E Sands. (2018) ACG Clinical Guideline: Management of Crohn's Disease in Adults. American Journal of Gastroenterology 113:4, pages 481-517.
Crossref
Crossref
Robert Hodgson, Matthew Walton, Mousumi Biswas, Teumzghi Mebrahtu & Nerys Woolacott. (2017) Ustekinumab for Treating Moderately to Severely Active Crohn’s Disease after Prior Therapy: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics 36:4, pages 387-398.
Crossref
Crossref
Fumihito Hirai, Akira Andoh, Fumiaki Ueno, Kenji Watanabe, Naoki Ohmiya, Hiroshi Nakase, Shingo Kato, Motohiro Esaki, Yutaka Endo, Hironori Yamamoto, Toshiyuki Matsui, Mitsuo Iida, Toshifumi Hibi, Mamoru Watanabe, Yasuo Suzuki & Takayuki Matsumoto. (2018) Efficacy of Endoscopic Balloon Dilation for Small Bowel Strictures in Patients With Crohn’s Disease: A Nationwide, Multi-centre, Open-label, Prospective Cohort Study. Journal of Crohn's and Colitis 12:4, pages 394-401.
Crossref
Crossref
Heidi Kammerlander, Jan Nielsen, Jens Kjeldsen, Torben Knudsen, Kim Oren Gradel, Sonia Friedman & Bente Mertz Nørgård. (2018) Fecal Calprotectin During Pregnancy in Women With Moderate-Severe Inflammatory Bowel Disease. Inflammatory Bowel Diseases 24:4, pages 839-848.
Crossref
Crossref
A. L. Lightner, N. P. McKenna, C. S. Tse, L. E. Raffals, E. V. LoftusJr.Jr. & K. L. Mathis. (2018) Postoperative outcomes in vedolizumab-treated Crohn's disease patients undergoing major abdominal operations. Alimentary Pharmacology & Therapeutics 47:5, pages 573-580.
Crossref
Crossref
Petra Weimers & Pia Munkholm. (2018) The Natural History of IBD: Lessons Learned. Current Treatment Options in Gastroenterology 16:1, pages 101-111.
Crossref
Crossref
Amy L Lightner. (2018) Segmental Resection versus Total Proctocolectomy for Crohn’s Colitis: What is the Best Operation in the Setting of Medically Refractory Disease or Dysplasia?. Inflammatory Bowel Diseases 24:3, pages 532-538.
Crossref
Crossref
Mahesh Gajendran, Priyadarshini Loganathan, Anthony P. Catinella & Jana G. Hashash. (2018) A comprehensive review and update on Crohn's disease. Disease-a-Month 64:2, pages 20-57.
Crossref
Crossref
Lung-Yi Mak, Siew C Ng, Irene O L Wong, Michael K K Li, F H Lo, Marc T L Wong, C M Leung, Steven W C Tsang, K H Chan, S F Sze, Edwin H S Shan, Belsy C Y Lam, Aric J Hui, Ivan F N Hung & Wai K Leung. (2018) Direct health-care cost utilization in Hong Kong inflammatory bowel disease patients in the initial 2 years following diagnosis. Journal of Gastroenterology and Hepatology 33:1, pages 141-149.
Crossref
Crossref
Jae Hee Cheon. 2018. Advances in Endoscopy in Inflammatory Bowel Disease. Advances in Endoscopy in Inflammatory Bowel Disease
85
99
.
Wee Khoon Ng & Siew C. Ng. 2018. Fibrostenotic Inflammatory Bowel Disease. Fibrostenotic Inflammatory Bowel Disease
5
12
.
Gabriele Bislenghi & Andre D’Hoore. 2018. Fibrostenotic Inflammatory Bowel Disease. Fibrostenotic Inflammatory Bowel Disease
267
293
.
Talat Bessissow & Gert Van Assche. 2018. Fibrostenotic Inflammatory Bowel Disease. Fibrostenotic Inflammatory Bowel Disease
225
232
.
Byron P. Vaughn. 2018. Treatment of Inflammatory Bowel Disease with Biologics. Treatment of Inflammatory Bowel Disease with Biologics
33
48
.
Webber Chan, Hang Hock Shim, Miao Shan Lim, Fatimin Leila Bahjin Sawadjaan, Sangeetha Poongunam Isaac, Sai Wei Chuah, Rupert Leong & Chris Kong. (2017) Symptoms of anxiety and depression are independently associated with inflammatory bowel disease-related disability. Digestive and Liver Disease 49:12, pages 1314-1319.
Crossref
Crossref
Heidi Kammerlander, Jan Nielsen, Torben Knudsen, Jens Kjeldsen, Sonia Friedman & Bente Mertz Nørgård. (2017) Anti–TNF-α Use During the Third Trimester of Pregnancy in Women with Moderate–severe Inflammatory Bowel Disease and the Risk of Preterm Birth and Low Birth Weight. Inflammatory Bowel Diseases 23:11, pages 1916-1923.
Crossref
Crossref
Roberto Candia, David Naimark, Beate Sander & Geoffrey C. Nguyen. (2017) Cost–utility Analysis. Inflammatory Bowel Diseases 23:11, pages 1930-1940.
Crossref
Crossref
Toshifumi Hibi, Remo Panaccione, Miiko Katafuchi, Kaoru Yokoyama, Kenji Watanabe, Toshiyuki Matsui, Takayuki Matsumoto, Simon Travis & Yasuo Suzuki. (2017) The 5C Concept and 5S Principles in Inflammatory Bowel Disease Management. Journal of Crohn's and Colitis 11:11, pages 1302-1308.
Crossref
Crossref
Kwan Mo Yang, Chang Sik Yu, Jong Lyul Lee, Chan Wook Kim, Yong Sik Yoon, In Ja Park, Seok-Byung Lim, Sang Hyoung Park, Byong Duk Ye, Suk-Kyun Yang & Jin Cheon Kim. (2017) Risk factors for postoperative recurrence after primary bowel resection in patients with Crohn’s disease. World Journal of Gastroenterology 23:38, pages 7016-7024.
Crossref
Crossref
Raina Shivashankar & Darrell S. Pardi. (2017) Use of Anti–Tumor Necrosis Factors and Anti-Integrins in the Treatment of Crohn's Disease. Gastroenterology Clinics of North America 46:3, pages 589-601.
Crossref
Crossref
Satimai Aniwan, Sang Hyoung Park & Edward V. LoftusJr.Jr.. (2017) Epidemiology, Natural History, and Risk Stratification of Crohn's Disease. Gastroenterology Clinics of North America 46:3, pages 463-480.
Crossref
Crossref
Heidi Kammerlander, Jan Nielsen, Jens Kjeldsen, Torben Knudsen, Sonia Friedman & Bente Nørgård. (2017) The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease. Inflammatory Bowel Diseases 23:6, pages 1011-1018.
Crossref
Crossref
James Irwin, Emma Ferguson, Lisa A. Simms, Katherine Hanigan, Franck Carbonnel & Graham Radford-Smith. (2017) A rolling phenotype in Crohn's disease. PLOS ONE 12:4, pages e0174954.
Crossref
Crossref
Navjot Deol, Tran M Nguyen, Claire E Parker, Reena Khanna, Brian G Feagan, John K MacDonald & Vipul Jairath. (2017) Infliximab for induction of remission in Crohn's disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Robert Battat, Navjot Deol, Tran M Nguyen, Claire E Parker, Reena Khanna, Brian G Feagan & Vipul Jairath. (2017) Infliximab for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Giorgia Bodini, Edoardo G. Giannini, Costanza De Maria, Pietro Dulbecco, Manuele Furnari, Elisa Marabotto, Vincenzo Savarino & Edoardo Savarino. (2017) Anti-TNF therapy is able to stabilize bowel damage progression in patients with Crohn’s disease. A study performed using the Lémann Index. Digestive and Liver Disease 49:2, pages 175-180.
Crossref
Crossref
Fumihito Hirai. (2017) Current status of endoscopic balloon dilation for Crohn's disease. Intestinal Research 15:2, pages 166.
Crossref
Crossref
Giovanni C Actis & Rinaldo Pellicano. (2017) Inflammatory bowel disease: Efficient remission maintenance is crucial for cost containment. World Journal of Gastrointestinal Pharmacology and Therapeutics 8:2, pages 114.
Crossref
Crossref
Sharon Dudley-Brown. (2017) Optimizing Inflammatory Bowel Disease Management. Gastroenterology Nursing 40:1S, pages S1-S14.
Crossref
Crossref
Allison L. Goetsch, Dana Kimelman & Teresa K. WoodruffAllison L. Goetsch, Dana Kimelman & Teresa K. Woodruff. 2017. Fertility Preservation and Restoration for Patients with Complex Medical Conditions. Fertility Preservation and Restoration for Patients with Complex Medical Conditions
249
266
.
Benjamin Sahn & James Markowitz. 2017. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
87
94
.
Amy Grant & Anthony Otley. 2017. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
625
638
.
Jacques Cosnes & Harry Sokol. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
653
660
.
Charles N. Bernstein. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
301
309
.
Katrine Carlsen, Pia Munkholm & Johan Burisch. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
279
289
.
Britt Christensen & David T. Rubin. 2017. Crohn's Disease and Ulcerative Colitis. Crohn's Disease and Ulcerative Colitis
267
277
.
J.-S. Lee, H.-J. Kim, H.-M. Cho, K.-M. Lee & B.-H. Kye. (2016) The importance of the Crohn's disease activity index in surgery for small bowel Crohn's disease. Journal of Visceral Surgery 153:5, pages 339-345.
Crossref
Crossref
J.-S. Lee, H.-J. Kim, H.-M. Cho, K.-M. Lee & B.-H. Kye. (2016) Place de l’index d’activité de la maladie de Crohn dans la prise en charge chirurgicale. Journal de Chirurgie Viscérale 153:5, pages 354-360.
Crossref
Crossref
Dario Sorrentino, Vu Nguyen, Carl Henderson & Adegabenga Bankole. (2016) Therapeutic Drug Monitoring and Clinical Outcomes in Immune Mediated Diseases. Inflammatory Bowel Diseases 22:10, pages 2527-2537.
Crossref
Crossref
Fernando T. Veloso. (2016) Clinical predictors of Crohn’s disease course. European Journal of Gastroenterology & Hepatology 28:10, pages 1122-1125.
Crossref
Crossref
Hannah Yarrow. (2016) Understanding Crohn's disease. Independent Nurse 2016:14, pages 17-21.
Crossref
Crossref
Yoo Min Han, Ji Won Kim, Seong-Joon Koh, Byeong Gwan Kim, Kook Lae Lee, Jong Pil Im, Joo Sung Kim & Hyun Chae Jung. (2016) Patients with perianal Crohn's disease have poor disease outcomes after primary bowel resection. Journal of Gastroenterology and Hepatology 31:8, pages 1436-1442.
Crossref
Crossref
Florian Rieder, Giovanni Latella, Fernando Magro, Elif S. Yuksel, Peter D. R. Higgins, Antonio Di Sabatino, Jessica R. de Bruyn, Jordi Rimola, Jorge Brito, Dominik Bettenworth, Gert van Assche, Willem Bemelman, Andre d’Hoore, Gianluca Pellino & Axel U. Dignass. (2016) European Crohn’s and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn’s Disease. Journal of Crohn's and Colitis 10:8, pages 873-885.
Crossref
Crossref
Christine Schmid-Tannwald, Christoph M. Schmid-Tannwald, John N. Morelli, Nathalie L. Albert, Margarita Braunagel, Christoph Trumm, Maximilian F. Reiser, Birgit Ertl-Wagner & Carsten Rist. (2016) The role of diffusion-weighted MRI in assessment of inflammatory bowel disease. Abdominal Radiology 41:8, pages 1484-1494.
Crossref
Crossref
Sang Hyoung Park, Sung Wook Hwang, Min Seob Kwak, Wan Soo Kim, Jeong-Mi Lee, Ho-Su Lee, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim & Suk-Kyun Yang. (2016) Long-Term Outcomes of Infliximab Treatment in 582 Korean Patients with Crohn’s Disease: A Hospital-Based Cohort Study. Digestive Diseases and Sciences 61:7, pages 2060-2067.
Crossref
Crossref
Kelly A. Mullican & Suzanne J. Francart. (2016) The role of specialty pharmacy drugs in the management of inflammatory diseases. American Journal of Health-System Pharmacy 73:11, pages 821-830.
Crossref
Crossref
Bhavana Bhagya Rao, Ioannis E. Koutroubakis, Claudia Ramos Rivers, Miguel Regueiro, Jason Swoger, Marc Schwartz, Leonard Baidoo, Jana Hashash, Arthur Barrie, Michael A. Dunn & David G. Binion. (2016) Correlation of anemia status with worsening bowel damage as measured by Lémann Index in patients with Crohn's disease. Digestive and Liver Disease 48:6, pages 626-631.
Crossref
Crossref
P. Malmborg & H. Hildebrand. (2016) The emerging global epidemic of paediatric inflammatory bowel disease - causes and consequences. Journal of Internal Medicine 279:3, pages 241-258.
Crossref
Crossref
Roxana Zaharie, Alina Tantau, Florin Zaharie, Marcel Tantau, Liana Gheorghe, Cristian Gheorghe, Serban Gologan, Cristina Cijevschi, Anca Trifan, Daniela Dobru, Adrian Goldis, Gabriel Constantinescu, Razvan Iacob & Mircea Diculescu. (2016) Diagnostic Delay in Romanian Patients with Inflammatory Bowel Disease: Risk Factors and Impact on the Disease Course and Need for Surgery. Journal of Crohn's and Colitis 10:3, pages 306-314.
Crossref
Crossref
Jan Wehkamp, Martin Götz, Klaus Herrlinger, Wolfgang Steurer & Eduard F. Stange. (2016) Inflammatory Bowel Disease: Crohn’s disease and ulcerative colitis. Deutsches Ärzteblatt international.
Crossref
Crossref
Louise Maagaard, Dorit V Ankersen, Zsuzsanna Végh, Johan Burisch, Lisbeth Jensen, Natalia Pedersen & Pia Munkholm. (2016) Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet. World Journal of Gastroenterology 22:15, pages 4009.
Crossref
Crossref
Andrea Affronti, Ambrogio Orlando & Mario Cottone. 2016. Crohn’s Disease. Crohn’s Disease
31
42
.
Marta Mazza, Maria Giovanna Cilluffo & Maria Cappello. 2016. Crohn’s Disease. Crohn’s Disease
7
14
.
Johan Burisch & Pia Munkholm. 2016. Telemanagement of Inflammatory Bowel Disease. Telemanagement of Inflammatory Bowel Disease
85
99
.
A. L. Bennett, S. Buckton, I. Lawrance, R. W. Leong, G. Moore & J. M. Andrews. (2015) Ulcerative colitis outpatient management: development and evaluation of tools to support primary care practitioners. Internal Medicine Journal 45:12, pages 1254-1266.
Crossref
Crossref
Talha A. Malik. (2015) Inflammatory Bowel Disease. Surgical Clinics of North America 95:6, pages 1105-1122.
Crossref
Crossref
Gil Y. Melmed & Stephan R. Targan. 2015. Yamada' s Textbook of Gastroenterology. Yamada' s Textbook of Gastroenterology
1418
1449
.
Joseph Tkacz, Brenna L. Brady, Roxanne Meyer, Jennifer H. Lofland, Charles Ruetsch & Nayantara Coelho-Prabhu. (2015) An Assessment of the AGA and CCFA Quality Indicators in a Sample of Patients Diagnosed with Inflammatory Bowel Disease. Journal of Managed Care & Specialty Pharmacy 21:11, pages 1064-1076.
Crossref
Crossref
Ioannis E. Koutroubakis, Claudia Ramos–Rivers, Miguel Regueiro, Efstratios Koutroumpakis, Benjamin Click, Robert E. Schoen, Jana G. Hashash, Marc Schwartz, Jason Swoger, Leonard Baidoo, Arthur Barrie, Michael A. Dunn & David G. Binion. (2015) Persistent or Recurrent Anemia Is Associated With Severe and Disabling Inflammatory Bowel Disease. Clinical Gastroenterology and Hepatology 13:10, pages 1760-1766.
Crossref
Crossref
Cyrielle Gilletta, Maïté Lewin, Anne Bourrier, Isabelle Nion-Larmurier, Sylvie Rajca, Laurent Beaugerie, Harry Sokol, Benjamin Pariente, Philippe Seksik & Jacques Cosnes. (2015) Changes in the Lémann Index Values During the First Years of Crohn’s Disease. Clinical Gastroenterology and Hepatology 13:9, pages 1633-1640.e3.
Crossref
Crossref
Petra A Golovics, Laszlo Lakatos, Michael D Mandel, Barbara D Lovasz, Zsuzsanna Vegh, Zsuzsanna Kurti, Istvan Szita, Lajos S Kiss, Tunde Pandur & Peter L Lakatos. (2015) Prevalence and predictors of hospitalization in Crohn’s disease in a prospective population-based inception cohort from 2000-2012. World Journal of Gastroenterology 21:23, pages 7272-7280.
Crossref
Crossref
Yoo Min Lee, Ben Kang, Yoon Lee, Mi Jin Kim & Yon Ho Choe. (2015) Infliximab “Top-Down” Strategy is Superior to “Step-Up” in Maintaining Long-Term Remission in the Treatment of Pediatric Crohn Disease. Journal of Pediatric Gastroenterology & Nutrition 60:6, pages 737-743.
Crossref
Crossref
Guillaume Bouguen, Barrett G. Levesque, Brian G. Feagan, Arthur Kavanaugh, Laurent Peyrin–Biroulet, Jean–Frederic Colombel, Stephen B. Hanauer & William J. Sandborn. (2015) Treat to Target: A Proposed New Paradigm for the Management of Crohn's Disease. Clinical Gastroenterology and Hepatology 13:6, pages 1042-1050.e2.
Crossref
Crossref
Petter Malmborg, Lena Grahnquist, Maja Ideström, Johan Lindholm, Ragnar Befrits, Jan Björk, Scott Montgomery & Hans Hildebrand. (2015) Presentation and Progression of Childhood-Onset Inflammatory Bowel Disease in Northern Stockholm County. Inflammatory Bowel Diseases 21:5, pages 1098-1108.
Crossref
Crossref
Amy Lewis, Anke Nijhuis, Shameer Mehta, Tomoko Kumagai, Roger Feakins, James O. Lindsay & Andrew Silver. (2015) Intestinal Fibrosis in Crohnʼs Disease. Inflammatory Bowel Diseases 21:5, pages 1141-1150.
Crossref
Crossref
Helioswilton Sales-Campos, Patricia Reis de Souza, Paulo José Basso, Anderson Daniel Ramos, Viviani Nardini, Javier Emílio Lazo Chica, Margareth Lara Capurro, Anderson Sá-Nunes & Cristina Ribeiro de Barros Cardoso. (2015) Aedes aegypti salivary gland extract ameliorates experimental inflammatory bowel disease. International Immunopharmacology 26:1, pages 13-22.
Crossref
Crossref
Alice L Bennett, Pia Munkholm & Jane M Andrews. (2015) Tools for primary care management of inflammatory bowel disease: Do they exist?. World Journal of Gastroenterology 21:15, pages 4457-4465.
Crossref
Crossref
Sang Mok LeeEon Chul HanSeung-Bum RyooHeung-Kwon OhEun Kyung ChoeSang Hui MoonJoo Sung KimHyun Chae JungKyu Joo Park. (2015) Long-term Outcomes and Risk Factors for Reoperation After Surgical Treatment for Gastrointestinal Crohn Disease According to Anti-tumor Necrosis Factor-α Antibody Use: 35 Years of Experience at a Single Institute in Korea. Annals of Coloproctology 31:4, pages 144.
Crossref
Crossref
Britta Siegmund. (2015) Medical Therapy of Fibrostenotic Crohn's Disease. Visceral Medicine 31:4, pages 259-264.
Crossref
Crossref
Mi Sung Park, Dong Hyun Kim, Duk Hwan Kim, Soo Jung Park, Sung Pil Hong, Tae Il Kim, Won Ho Kim & Jae Hee Cheon. (2014) Leukopenia Predicts Remission in Patients with Inflammatory Bowel Disease and Behcet’s Disease on Thiopurine Maintenance. Digestive Diseases and Sciences 60:1, pages 195-204.
Crossref
Crossref
Tauseef Ali. 2015. Inflammatory Bowel Disease. Inflammatory Bowel Disease
35
39
.
Mark A. Samaan & Geert D’Haens. 2015. Endoscopy in Inflammatory Bowel Disease. Endoscopy in Inflammatory Bowel Disease
205
226
.
Min Seob Kwak, Duk Hwan Kim, Soo Jung Park, Tae Il Kim, Sung Pil Hong, Won Ho Kim & Jae Hee Cheon. (2014) Efficacy of early immunomodulator therapy on the outcomes of Crohn’s disease. BMC Gastroenterology 14:1.
Crossref
Crossref
Marianne K. Vester-Andersen, Ida Vind, Michelle V. Prosberg, Bo G. Bengtsson, Thomas Blixt, Pia Munkholm, Mikael Andersson, Tine Jess & Flemming Bendtsen. (2014) Hospitalisation, surgical and medical recurrence rates in inflammatory bowel disease 2003–2011—A Danish population-based cohort study. Journal of Crohn's and Colitis 8:12, pages 1675-1683.
Crossref
Crossref
Michael D. Mandel, Anita Balint, Petra A. Golovics, Zsuzsanna Vegh, Anna Mohas, Blanka Szilagyi, Agnes Szabo, Zsuzsanna Kurti, Lajos S. Kiss, Barbara D. Lovasz, Krisztina B. Gecse, Klaudia Farkas, Tamas Molnar & Peter L. Lakatos. (2014) Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centres. Digestive and Liver Disease 46:11, pages 985-990.
Crossref
Crossref
Ambrogio Orlando, Filippo Mocciaro, Sara Renna, Daniela Scimeca, Antonio Rispo, Maria Lia Scribano, Anna Testa, Annalisa Aratari, Fabrizio Bossa, Rosy Tambasco, Erika Angelucci, Sara Onali, Maria Cappello, Walter Fries, Renata D'Incà, Matteo Martinato, Fabiana Castiglione, Claudio Papi, Vito Annese, Paolo Gionchetti, Fernando Rizzello, Piero Vernia, Livia Biancone, Anna Kohn & Mario Cottone. (2014) Early post-operative endoscopic recurrence in Crohn's disease patients: Data from an Italian Group for the study of inflammatory bowel disease (IG-IBD) study on a large prospective multicenter cohort. Journal of Crohn's and Colitis 8:10, pages 1217-1221.
Crossref
Crossref
Laurent Beaugerie, Fabrice Carrat, Jean-Frédéric Colombel, Anne-Marie Bouvier, Harry Sokol, Abdenour Babouri, Franck Carbonnel, David Laharie, Jean-Luc Faucheron, Tabassome Simon, Aimery de Gramont & Laurent Peyrin-Biroulet. (2014) Risk of new or recurrent cancer under immunosuppressive therapy in patients with IBD and previous cancer. Gut 63:9, pages 1416-1423.
Crossref
Crossref
Aurelien Amiot, Vida Setakhr, Philippe Seksik, Mathieu Allez, Xavier Treton, Martine De Vos, David Laharie, Jean-Frederic Colombel, Vered Abitbol, Jean Marie Reimund, Jacques Moreau, Michel Veyrac, Bernard Flourié, Jacques Cosnes, Marc Lemann & Yoram Bouhnik. (2014) Long-Term Outcome of Enterocutaneous Fistula in Patients With Crohn's Disease Treated With Anti-TNF Therapy: A Cohort Study from the GETAID. American Journal of Gastroenterology 109:9, pages 1443-1449.
Crossref
Crossref
Viraj C. Kariyawasam, Christian P. Selinger, Peter H. Katelaris, D. Brian Jones, Charles McDonald, Gavin Barr, Grace Chapman, James Colliwshaw, Paul C. Lunney, Kate Middleton, Rosy R. Wang, Tony Huang, Jane Andrews & Rupert W. Leong. (2014) Early Use of Thiopurines or Methotrexate Reduces Major Abdominal and Perianal Surgery in Crohnʼs Disease. Inflammatory Bowel Diseases 20:8, pages 1382-1390.
Crossref
Crossref
Fumihito Hirai, Takahiro Beppu, Noritaka Takatsu, Yutaka Yano, Kazeo Ninomiya, Yoichiro Ono, Takashi Hisabe & Toshiyuki Matsui. (2014) Long-term outcome of endoscopic balloon dilation for small bowel strictures in patients with Crohn's disease. Digestive Endoscopy 26:4, pages 545-551.
Crossref
Crossref
Harry Sokol, Philippe Seksik & Jacques Cosnes. (2014) Complications and surgery in the inflammatory bowel diseases biological era. Current Opinion in Gastroenterology 30:4, pages 378-384.
Crossref
Crossref
Marianne K Vester-Andersen, Michelle V Prosberg, Tine Jess, Mikael Andersson, Bo G Bengtsson, Thomas Blixt, Pia Munkholm, Flemming Bendtsen & Ida Vind. (2014) Disease Course and Surgery Rates in Inflammatory Bowel Disease: A Population-Based, 7-Year Follow-Up Study in the Era of Immunomodulating Therapy. American Journal of Gastroenterology 109:5, pages 705-714.
Crossref
Crossref
Malcolm Tan, Jeannie PL Ong & Eng Kiong Teo. (2014) Achieving Deep Remission in Crohn’s Disease: Treating Beyond Symptoms. Annals of the Academy of Medicine, Singapore 43:4, pages 200-202.
Crossref
Crossref
Dario Sorrentino, Peter Nash, Monica Viladomiu, Raquel Hontecillas & Josep Bassaganya-Riera. (2014) Stopping Anti-TNF Agents in Patients with Crohnʼs Disease in Remission. Inflammatory Bowel Diseases 20:4, pages 757-766.
Crossref
Crossref
Sukhdev Chatu, Sonia Saxena, Venkataraman Subramanian, Vasa Curcin, Ghasem Yadegarfar, Laura Gunn, Azeem Majeed & Richard C G Pollok. (2014) The Impact of Timing and Duration of Thiopurine Treatment on First Intestinal Resection in Crohn's Disease: National UK Population-Based Study 1989–2010. American Journal of Gastroenterology 109:3, pages 409-416.
Crossref
Crossref
Edward V. LoftusJr.Jr.. 2014. GI Epidemiology. GI Epidemiology
273
284
.
Klaus R. Herrlinger & Eduard F. Stange. (2014) The debated role for thiopurines in Crohn's disease. Journal of Crohn's and Colitis 8:2, pages 172-174.
Crossref
Crossref
Tiago Nunes, Maria Josefina Etchevers, Maria Jose Sandi, Susana Pinó Donnay, Teddy Grandjean, Maria Pellisé, Julián Panés, Elena Ricart, Juan Lucio Iovanna, Jean-Charles Dagorn, Mathias Chamaillard & Miquel Sans. (2014) Pancreatitis-Associated Protein Does Not Predict Disease Relapse in Inflammatory Bowel Disease Patients. PLoS ONE 9:1, pages e84957.
Crossref
Crossref
Shota Saito, Utako Shimizu, Zhang Nan, Junji Yokoyama, Mayumi Watanabe, Kenshi Terajima & Kohei Akazawa. (2014) A health economic analysis of combination therapy with infliximab plus elemental diet for moderately to severely active Crohn’s disease. Health 06:01, pages 107-114.
Crossref
Crossref
Roberta Elisa Rossi. (2014) Anti-tumour necrosis factor agent and liver injury: Literature review, recommendations for management. World Journal of Gastroenterology 20:46, pages 17352.
Crossref
Crossref
Rong Fan. (2014) Evaluation of “top-down” treatment of early Crohn’s disease by double balloon enteroscopy. World Journal of Gastroenterology 20:39, pages 14479.
Crossref
Crossref
Michael D. Mandel, Pal Miheller, Katalin Müllner, Petra A. Golovics & Peter L. Lakatos. (2014) Have Biologics Changed the Natural History of Crohn's Disease?. Digestive Diseases 32:4, pages 351-359.
Crossref
Crossref
Jose-Manuel Benitez & Edouard Louis. (2014) Can We Predict the High-Risk Patient?. Digestive Diseases 32:4, pages 328-336.
Crossref
Crossref
Hirotake Sakuraba, Yoh Ishiguro, Keisuke Hasui, Hiroto Hiraga, Shinsaku Fukuda, Koichi Shibutani & Yoshihiro Takai. (2014) Prediction of Maintained Mucosal Healing in Patients with Crohn's Disease under Treatment with Infliximab Using Diffusion-Weighted Magnetic Resonance Imaging. Digestion 89:1, pages 49-54.
Crossref
Crossref
Johan Burisch, Natalia Pedersen, Silvja Cukovic-Cavka, Niksa Turk, Ioannis Kaimakliotis, Dana Duricova, Olga Shonová, Ida Vind, Søren Avnstrøm, Niels Thorsgaard, Susanne Krabbe, Vibeke Andersen, Frederik Dahlerup Jens, Jens Kjeldsen, Riina Salupere, Jónger Olsen, Kári Rubek Nielsen, Pia Manninen, Pekka Collin, Konstantinnos H. Katsanos, Epameinondas V. Tsianos, Karin Ladefoged, Laszlo Lakatos, Yvonne Bailey, Colm O’Morain, Doron Schwartz, Selwyn Odes, Matteo Martinato, Silvia Lombardini, Laimas Jonaitis, Limas Kupcinskas, Svetlana Turcan, Louisa Barros, Fernando Magro, Daniela Lazar, Adrian Goldis, Inna Nikulina, Elena Belousova, Alberto Fernandez, Vicent Hernandez, Sven Almer, Yaroslava Zhulina, Jonas Halfvarson, Her-Hsin Tsai, Shaji Sebastian, Peter Laszlo Lakatos, Ebbe Langholz & Pia Munkholm. (2014) Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe. Inflammatory Bowel Diseases 20:1, pages 36-46.
Crossref
Crossref
Yamile Zabana, Esther Garcia-Planella, Manuel van Domselaar, Míriam Mañosa, Jordi Gordillo, Antonio López-Sanromán, Eduard Cabré & Eugeni Domènech. (2013) Predictors of favourable outcome in inflammatory Crohn's disease. A retrospective observational study. Gastroenterología y Hepatología 36:10, pages 616-623.
Crossref
Crossref
Alain M Schoepfer, Mohamed-Ali Dehlavi, Nicolas Fournier, Ekaterina Safroneeva, Alex Straumann, Valérie Pittet, Laurent Peyrin-Biroulet, Pierre Michetti, Gerhard Rogler & Stephan R Vavricka. (2013) Diagnostic Delay in Crohn's Disease Is Associated With a Complicated Disease Course and Increased Operation Rate. American Journal of Gastroenterology 108:11, pages 1744-1753.
Crossref
Crossref
Jennifer C. C. deBruyn, Ing Shian Soon, James Hubbard, Iwona Wrobel, Remo Panaccione & Gilaad G. Kaplan. (2013) Nationwide Temporal Trends in Incidence of Hospitalization and Surgical Intestinal Resection in Pediatric Inflammatory Bowel Diseases in the United States from 1997 to 2009. Inflammatory Bowel Diseases 19:11, pages 2423-2432.
Crossref
Crossref
Jacques Cosnes, Anne Bourrier, David Laharie, Stéphane Nahon, Yoram Bouhnik, Franck Carbonnel, Matthieu Allez, Jean–Louis Dupas, Jean–Marie Reimund, Guillaume Savoye, Pauline Jouet, Jacques Moreau, Jean–Yves Mary & Jean–Frédéric Colombel. (2013) Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial. Gastroenterology 145:4, pages 758-765.e2.
Crossref
Crossref
W. Kruis, A. Katalinic, T. Klugmann, G.-R. Franke, J. Weismüller, L. Leifeld, S. Ceplis-Kastner, B. Reimers & B. Bokemeyer. (2013) Predictive factors for an uncomplicated long-term course of Crohn's disease: A retrospective analysis. Journal of Crohn's and Colitis 7:7, pages e263-e270.
Crossref
Crossref
Jie Han, Jian Wang & Jiaoying H. Wang. (2013) How to achieve deep remission in the treatment of inflammatory bowel disease. Journal of Traditional Chinese Medicine 33:4, pages 549-552.
Crossref
Crossref
Gary R. Lichtenstein. (2013) Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response. Therapeutic Advances in Gastroenterology 6:4, pages 269-293.
Crossref
Crossref
J. O. Lindsay, R. Chipperfield, A. Giles, C. Wheeler & T. Orchard. (2013)
A
UK
retrospective observational study of clinical outcomes and healthcare resource utilisation of infliximab treatment in Crohn's disease
. Alimentary Pharmacology & Therapeutics 38:1, pages 52-61.
Crossref
Crossref
Johan Burisch, Tine Jess, Matteo Martinato & Peter L. Lakatos. (2013) The burden of inflammatory bowel disease in Europe. Journal of Crohn's and Colitis 7:4, pages 322-337.
Crossref
Crossref
Ioannis E KoutroubakisMathurin FumeryJean-Louis DupasPierre Desreumaux. 2013. Advances in the Management of Inflammatory Bowel Disease. Advances in the Management of Inflammatory Bowel Disease
158
172
.
Mark T. Osterman. (2013) Mucosal Healing in Inflammatory Bowel Disease. Journal of Clinical Gastroenterology 47:3, pages 212-221.
Crossref
Crossref
P. B. Allen, M. A. Kamm, L. Peyrin‐Biroulet, C. Studd, C. Mc Dowell, B. C. M. Allen, W. R. Connell, P. P. De Cruz, S. J. Bell, R. P. Elliot, S. Brown, P. V. Desmond, M. Lemann & J.‐F. Colombel. (2012)
Development and validation of a patient‐reported disability measurement tool for patients with
inflammatory bowel disease
. Alimentary Pharmacology & Therapeutics 37:4, pages 438-444.
Crossref
Crossref
Yoon Suk Jung, Jae Hee Cheon, Soo Jung Park, Sung Pil Hong, Tae Il Kim & Won Ho Kim. (2012) Clinical Course of Intestinal Behcet’s Disease During the First Five Years. Digestive Diseases and Sciences 58:2, pages 496-503.
Crossref
Crossref
Peter De Cruz, Michael A. Kamm, Lani Prideaux, Patrick B. Allen & Greg Moore. (2013) Mucosal Healing in Crohnʼs Disease. Inflammatory Bowel Diseases 19:2, pages 429-444.
Crossref
Crossref
Yong Gil KimByung Ik Jang. (2013) The Role of Colonoscopy in Inflammatory Bowel Disease. Clinical Endoscopy 46:4, pages 317.
Crossref
Crossref
Govind Nandakumar & Fabrizio Michelassi. 2013. Shackelford's Surgery of the Alimentary Tract. Shackelford's Surgery of the Alimentary Tract
880
906
.
James F. Markowitz. 2013. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
65
71
.
Anthony Otley. 2013. Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease
491
503
.
N. Pedersen, M. Elkjaer, D. Duricova, J. Burisch, C. Dobrzanski, N. N. Andersen, T. Jess, F. Bendtsen, E. Langholz, S. Leotta, T. Knudsen, N. Thorsgaard & P. Munkholm. (2012) eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn's disease. Alimentary Pharmacology & Therapeutics 36:9, pages 840-849.
Crossref
Crossref
J. M. Otto, A. F. O’Doherty, P. J. Hennis, K. Mitchell, J. S. Pate, J. A. Cooper, M. P. W. Grocott & H. E. Montgomery. (2012) Preoperative exercise capacity in adult inflammatory bowel disease sufferers, determined by cardiopulmonary exercise testing. International Journal of Colorectal Disease 27:11, pages 1485-1491.
Crossref
Crossref
Michael J Stewart, Sushil K Garg, Cynthia H Seow & Martin Storr. (2012) Interventions for induction and maintenance of mucosal healing in Crohn's disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Bincy P. Abraham & Joseph H. Sellin. (2012) Disability in Inflammatory Bowel Disease. Gastroenterology Clinics of North America 41:2, pages 429-441.
Crossref
Crossref
Wojciech Blonski, Anna M. Buchner & Gary R. Lichtenstein. (2012) Clinical Predictors of Aggressive/Disabling Disease: Ulcerative Colitis and Crohn Disease. Gastroenterology Clinics of North America 41:2, pages 443-462.
Crossref
Crossref
Antony Cutler, John Girdlestone, Sally Hopewell, Simon Stanworth, Carolyn Doree, Francesco Dazzi, Vipul Jairath & Cristina Navarrete. (2012) Mesenchymal stromal cells (MSC) for treating immune-mediated inflammation post-transplantation and in autoimmunity. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Pál Miheller, Ferenc Nagy, Károly Palatka, István Altorjay, Gábor Horváth, Katalin Lőrinczy, László Újszászy, Zsolt Virányi, Attila Szepes, Tamás Molnár, Klaudia Farkas, Zoltán Szepes, Tibor Nyári, Tibor Wittmann & Zsolt Tulassay. (2012) Some data on inflammatory bowel diseases in Hungary: analytical data on ulcerative colistis. Orvosi Hetilap 153:18, pages 702-712.
Crossref
Crossref
Displaying 200 of 391 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list